CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials

1. JüniP

AltmanDG

EggerM

2001 Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 323 42 46

2. ChanAW

AltmanDG

2005 Epidemiology and reporting of randomised trials published in PubMed journals. Lancet 365 1159 1162

3. GlasziouP

MeatsE

HeneghanC

ShepperdS

2008 What is missing from descriptions of treatment in trials and reviews? BMJ 336 1472 1474

4. DwanK

AltmanDG

ArnaizJA

BloomJ

ChanAW

2008 Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS ONE 3 e3081 doi:10.1371/journal.pone.0003081

5. BeggC

ChoM

EastwoodS

HortonR

MoherD

1996 Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 276 637 639

6. MoherD

SchulzKF

AltmanDG

2001 The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357 1191 1194

7. MoherD

SchulzKF

AltmanDG

2001 The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med 134 657 662

8. MoherD

SchulzKF

AltmanD

2001 The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 285 1987 1991

9. PlintAC

MoherD

MorrisonA

SchulzK

AltmanDG

2006 Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. Med J Aust 185 263 267

10. HopewellS

DuttonS

YuL-M

ChanA-W

AltmanDG

2010 The quality of reports of randomised trials in 2000 and 2006: a comparative study of articles indexed by PubMed. BMJ 340 c723

11. CampbellMK

ElbourneDR

AltmanDG

2004 CONSORT statement: extension to cluster randomised trials. BMJ 328 702 708

12. PiaggioG

ElbourneDR

AltmanDG

PocockSJ

EvansSJ

2006 Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA 295 1152 1160

13. MoherD

HopewellS

SchulzKF

MontoriV

GøtzschePC

2010 CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 340 c869

14. SchulzKF

ChalmersI

HayesRJ

AltmanDG

1995 Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273 408 412

15. MoherD

PhamB

JonesA

CookDJ

JadadAR

1998 Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 352 609 613

16. MoherD

LiberatiA

TetzlaffJ

AltmanDG

The PRISMA Group 2009 Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6 e1000097 doi:10.1371/journal.pmed.1000097

17. BossuytPM

ReitsmaJB

BrunsDE

GatsonisCA

GlasziouPP

2003 Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ 326 41 44

18. von ElmE

AltmanDG

EggerM

PocockSJ

GøtzschePC

2007 Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335 806 808

19. Standards of Reporting Trials Group 1994 A proposal for structured reporting of randomized controlled trials. JAMA 272 1926 1931

20. RennieD

1995 Reporting randomized controlled trials. An experiment and a call for responses from readers. JAMA 273 1054 1055

21. HopewellS

ClarkeM

MoherD

WagerE

MiddletonP

2008 CONSORT for reporting randomised trials in journal and conference abstracts. Lancet 371 281 283

22. ChanAW

HróbjartssonA

HaahrMT

GøtzschePC

AltmanDG

2004 Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 291 2457 2465

23. SackettDL

2007 Commentary: Measuring the success of blinding in RCTs: don't, must, can't or needn't? Int J Epidemiol 36 664 665

24. SchulzKF

GrimesDA

2002 Blinding in randomised trials: hiding who got what. Lancet 359 696 700

25. MontoriVM

DevereauxPJ

AdhikariNK

BurnsKE

EggertCH

2203-2209 Randomized trials stopped early for benefit: a systematic review. JAMA

26. HollisS

CampbellF

1999 What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ 319 670 674

27. NuovoJ

MelnikowJ

ChangD

2002 Reporting number needed to treat and absolute risk reduction in randomized controlled trials. JAMA 287 2813 2814

28. IoannidisJP

EvansSJ

GøtzschePC

O'NeillRT

AltmanDG

2004 Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med 141 781 788

29. De AngelisC

DrazenJM

FrizelleFA

HaugC

HoeyJ

2004 Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Lancet 364 911 912

30. LexchinJ

BeroLA

DjulbegovicB

ClarkO

2003 Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 326 1167 1170

31. HopewellS

ClarkeM

MoherD

WagerE

MiddletonP

2008 CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration. PLoS Med 5 e20 doi:10.1371/journal.pmed.0050020

32. BoutronI

MoherD

AltmanDG

SchulzKF

RavaudP

2008 Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med 148 295 309

33. GagnierJJ

BoonH

RochonP

MoherD

BarnesJ

2006 Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement. Ann Intern Med 144 364 367

34. ZwarensteinM

TreweekS

GagnierJJ

AltmanDG

TunisS

2008 Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ 337 a2390